Literature DB >> 25317238

Prognostic value of endothelial dysfunction in type 1 diabetes mellitus.

Ana Marice Ladeia1, Raphael Ribeiro Sampaio1, Maiara Costa Hita1, Luis F Adan1.   

Abstract

Patients with diabetes mellitus are at high risk of developing atherosclerosis, associated with higher rates of micro and macro vascular involvement such as coronary artery disease and renal disease. The role of hyperglycemia to induce synthesis of reactive oxygen species by the oxidation of glucose, leading to an increased production of advanced glycosylation end products, as well as inflammation and oxidative stress has been proposed as a possible mechanism in the pathogenesis of endothelial dysfunction (ED). The interaction between C-peptide - the connecting segment of pro-insulin-and nitric oxide in vasodilation is also discussed. Therefore, endothelial dysfunction has been identified as an early marker of vascular disorder in type 1 and type 2 diabetes mellitus. In some other diseases, ED has been considered an independent predictor of vascular disease, regardless of the method used. Studies have demonstrated the importance of endothelial dysfunction as an useful tool for identifying the risk of vascular complications in patients with type 1 diabetes mellitus, particularly as regards to renal impairment. The aim of this review is to clarify the prognostic value of endothelial dysfunction as a marker of vascular disease in these subjects.

Entities:  

Keywords:  Cardiovascular disease; Endothelial dysfunction; Pathogenesis; Prognostic; Type1 diabetes

Year:  2014        PMID: 25317238      PMCID: PMC4138584          DOI: 10.4239/wjd.v5.i5.601

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  40 in total

Review 1.  Cellular and molecular mechanisms of endothelial dysfunction in diabetes.

Authors:  Anna C Roberts; Karen E Porter
Journal:  Diab Vasc Dis Res       Date:  2013-09-03       Impact factor: 3.291

2.  The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus.

Authors:  S P Laing; A J Swerdlow; S D Slater; J L Botha; A C Burden; N R Waugh; A W Smith; R D Hill; P J Bingley; C C Patterson; Z Qiao; H Keen
Journal:  Diabet Med       Date:  1999-06       Impact factor: 4.359

3.  Myogenic activity in isolated subepicardial and subendocardial coronary arterioles.

Authors:  L Kuo; M J Davis; W M Chilian
Journal:  Am J Physiol       Date:  1988-12

4.  The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial.

Authors:  A Rafnsson; F Böhm; M Settergren; A Gonon; K Brismar; J Pernow
Journal:  Diabetologia       Date:  2011-12-27       Impact factor: 10.122

Review 5.  Diabetes mellitus and ischemic diseases: molecular mechanisms of vascular repair dysfunction.

Authors:  Kiave Yune Howangyin; Jean-Sébastien Silvestre
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03-27       Impact factor: 8.311

6.  Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

Authors:  M T Johnstone; S J Creager; K M Scales; J A Cusco; B K Lee; M A Creager
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

7.  Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.

Authors:  H O Steinberg; G Brechtel; A Johnson; N Fineberg; A D Baron
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

8.  Nitric oxide release accounts for insulin's vascular effects in humans.

Authors:  U Scherrer; D Randin; P Vollenweider; L Vollenweider; P Nicod
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

Review 9.  Hemodynamic actions of insulin.

Authors:  A D Baron
Journal:  Am J Physiol       Date:  1994-08

Review 10.  Effects of C-peptide on microvascular blood flow and blood hemorheology.

Authors:  T Forst; T Kunt
Journal:  Exp Diabesity Res       Date:  2004 Jan-Mar
View more
  14 in total

1.  Advanced glycation end products upregulate angiopoietin-like protein 4 expression by activating the renin-angiotensin system in endothelial cells.

Authors:  Zhenda Zheng; Cailian Cheng; Ruimin Dong; Mei Li; Zhaojun Xiong; Xiaoxian Qian; Lin Chen
Journal:  Biomed Rep       Date:  2015-05-21

Review 2.  Diabetes and ageing-induced vascular inflammation.

Authors:  Mariam El Assar; Javier Angulo; Leocadio Rodríguez-Mañas
Journal:  J Physiol       Date:  2015-11-02       Impact factor: 5.182

3.  Expression of miR-217 and HIF-1α/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats.

Authors:  C-J Lin; Y-M Lan; M-Q Ou; L-Q Ji; S-D Lin
Journal:  J Endocrinol Invest       Date:  2019-05-11       Impact factor: 4.256

4.  Organ-on-chips made of blood: endothelial progenitor cells from blood reconstitute vascular thromboinflammation in vessel-chips.

Authors:  Tanmay Mathur; Kanwar Abhay Singh; Navaneeth K R Pandian; Shu-Huai Tsai; Travis W Hein; Akhilesh K Gaharwar; Jonathan M Flanagan; Abhishek Jain
Journal:  Lab Chip       Date:  2019-07-23       Impact factor: 6.799

Review 5.  The Role of Polyphenol in Modulating Associated Genes in Diabetes-Induced Vascular Disorders.

Authors:  Nor Anizah Mohd Nor; Siti Balkis Budin; Satirah Zainalabidin; Juriyati Jalil; Syaifuzah Sapian; Fatin Farhana Jubaidi; Nur Najmi Mohamad Anuar
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

6.  Enhanced A2A adenosine receptor-mediated increase in coronary flow in type I diabetic mice.

Authors:  Hicham Labazi; Bunyen Teng; Zhichao Zhou; S Jamal Mustafa
Journal:  J Mol Cell Cardiol       Date:  2015-12-02       Impact factor: 5.000

7.  Functional and morphological changes in endocrine pancreas following cola drink consumption in rats.

Authors:  Matilde Otero-Losada; Gabriel Cao; Julián González; Angélica Muller; Graciela Ottaviano; Christopher Lillig; Francisco Capani; Giuseppe Ambrosio; José Milei
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

8.  Exogenous Angiotensin I Metabolism in Aorta Isolated from Streptozotocin Treated Diabetic Rats.

Authors:  P P Wołkow; B Bujak-Giżycka; J Jawień; R Olszanecki; J Madej; J Rutowski; R Korbut
Journal:  J Diabetes Res       Date:  2016-10-10       Impact factor: 4.011

9.  Blocking 5-HT2 receptor restores cardiovascular disorders in type 1 experimental diabetes.

Authors:  José-Ángel García-Pedraza; Pedro Ferreira-Santos; Rubén Aparicio; María-José Montero; Asunción Morán
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

10.  Hypochlorite-Modified Albumin Upregulates ICAM-1 Expression via a MAPK-NF-κB Signaling Cascade: Protective Effects of Apocynin.

Authors:  Dong-dong Tang; Hong-xin Niu; Fen-fen Peng; Hai-bo Long; Zong-rui Liu; Hao Zhao; Yi-hua Chen
Journal:  Oxid Med Cell Longev       Date:  2016-01-10       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.